Ian Scholes
Vorstandsvorsitzender bei Chord Capital Pty Ltd.
Profil
Ian Frank Scholes is currently the Chief Executive Officer & Partner at Chord Capital Pty Ltd.
He previously worked as the Vice Chairman-Investment Banking at Merrill Lynch (Australia) Pty Ltd.
He was also the Deputy Chairman at Mayne Pharma Group Ltd.
from 2021 to 2022.
He served as a Non-Executive Director at Halcygen Pharmaceuticals Ltd.
from 2007 to 2010.
In addition, he was an Independent Non-Executive Director at SDI Ltd.
in 2013.
He also worked as an Executive General Manager at National Australia Bank Ltd.
Mr. Scholes received his undergraduate degree from the University of Melbourne.
Aktive Positionen von Ian Scholes
| Unternehmen | Position | Beginn |
|---|---|---|
| Chord Capital Pty Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Ian Scholes
| Unternehmen | Position | Ende |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Direktor/Vorstandsmitglied | 30.09.2022 |
| SDI LIMITED | Direktor/Vorstandsmitglied | 02.08.2013 |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Direktor/Vorstandsmitglied | 22.11.2010 |
Merrill Lynch (Australia) Pty Ltd.
 Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Part of Bank of America Corp., Merrill Lynch (Australia) Pty Ltd. is an Australian company that provides online lease financing services. The company is based in Sydney, Australia. | Corporate Officer/Principal | - |
St. Vincent Health, Inc.
 St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services St. Vincent Health, Inc. is a non-profit organization which operates general hospitals and specialty hospitals. The company is headquartered in Indianapolis, IN. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ian Scholes
| University of Melbourne | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| NATIONAL AUSTRALIA BANK LIMITED | Finance |
| SDI LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
St. Vincent Health, Inc.
St. Vincent Health, Inc. Hospital/Nursing ManagementHealth Services St. Vincent Health, Inc. is a non-profit organization which operates general hospitals and specialty hospitals. The company is headquartered in Indianapolis, IN. | Health Services |
Merrill Lynch (Australia) Pty Ltd.
Merrill Lynch (Australia) Pty Ltd. Financial ConglomeratesFinance Part of Bank of America Corp., Merrill Lynch (Australia) Pty Ltd. is an Australian company that provides online lease financing services. The company is based in Sydney, Australia. | Finance |
| Chord Capital Pty Ltd. |
